TEMPO, which stands for a web-based, Tailored, sElf-Management PrOgram, was developed to support men with prostate cancer and their caregivers. Initially piloted through a randomized controlled trial, TEMPO demonstrated promising improvements in coping skills, communication, and physical activity levels among participants. This presentation outlined TEMPO’s initial development and pilot study findings. Speakers introduced the latest, large-scale sequential multiple assignment randomized trial (SMART) examining TEMPO’s efficacy and cost-effectiveness compared to usual care. This multi-stage, SMART seeks to evaluate the delivery of TEMPO using a stepped-care approach on anxiety and quality of life outcomes for patients and caregivers. Attendees gained insights into the methodology and anticipated impacts of this unique program, designed for self-directed use without healthcare professional involvement.
← Events